• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难溶性药物非晶化的最新技术

Recent Technologies for Amorphization of Poorly Water-Soluble Drugs.

作者信息

Kim Do-Hyun, Kim Young-Woo, Tin Yee-Yee, Soe Mya-Thet-Paing, Ko Byoung-Hyen, Park Sun-Jae, Lee Jaeh-Wi

机构信息

College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.

CAU-Myanmar Pacific Pharmaceutical Research Center, Chung-Ang University, Seoul 06974, Korea.

出版信息

Pharmaceutics. 2021 Aug 23;13(8):1318. doi: 10.3390/pharmaceutics13081318.

DOI:10.3390/pharmaceutics13081318
PMID:34452279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8399234/
Abstract

Amorphization technology has been the subject of continuous attention in the pharmaceutical industry, as a means to enhance the solubility of poorly water-soluble drugs. Being in a high energy state, amorphous formulations generally display significantly increased apparent solubility as compared to their crystalline counterparts, which may allow them to generate a supersaturated state in the gastrointestinal tract and in turn, improve the bioavailability. Conventionally, hydrophilic polymers have been used as carriers, in which the amorphous drugs were dispersed and stabilized to form polymeric amorphous solid dispersions. However, the technique had its limitations, some of which include the need for a large number of carriers, the tendency to recrystallize during storage, and the possibility of thermal decomposition of the drug during preparation. Therefore, emerging amorphization technologies have focused on the investigation of novel amorphous-stabilizing carriers and preparation methods that can improve the drug loading and the degree of amorphization. This review highlights the recent pharmaceutical approaches utilizing drug amorphization, such as co-amorphous systems, mesoporous particle-based techniques, and in situ amorphization. Recent updates on these technologies in the last five years are discussed with a focus on their characteristics and commercial potential.

摘要

非晶化技术一直是制药行业持续关注的课题,作为提高难溶性药物溶解度的一种手段。处于高能状态的无定形制剂通常比其结晶对应物表现出显著提高的表观溶解度,这可能使它们在胃肠道中产生过饱和状态,进而提高生物利用度。传统上,亲水性聚合物被用作载体,无定形药物分散并稳定在其中以形成聚合物无定形固体分散体。然而,该技术有其局限性,其中一些包括需要大量载体、储存期间重结晶的倾向以及药物在制备过程中热分解的可能性。因此,新兴的非晶化技术专注于研究能够提高药物载量和非晶化程度的新型非晶态稳定载体和制备方法。本综述重点介绍了最近利用药物非晶化的制药方法,如共无定形系统、介孔颗粒技术和原位非晶化。讨论了这些技术在过去五年中的最新进展,重点是它们的特点和商业潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b430/8399234/6bab744f7b5c/pharmaceutics-13-01318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b430/8399234/6bab744f7b5c/pharmaceutics-13-01318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b430/8399234/6bab744f7b5c/pharmaceutics-13-01318-g001.jpg

相似文献

1
Recent Technologies for Amorphization of Poorly Water-Soluble Drugs.难溶性药物非晶化的最新技术
Pharmaceutics. 2021 Aug 23;13(8):1318. doi: 10.3390/pharmaceutics13081318.
2
Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.三元固体分散体:制备、表征、药物释放机制及物理稳定性综述
Pharmaceutics. 2023 Aug 10;15(8):2116. doi: 10.3390/pharmaceutics15082116.
3
Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.近年来改善非水溶性药物在无定形药物固体中溶解和过饱和的进展:综述。
AAPS PharmSciTech. 2021 Dec 10;23(1):16. doi: 10.1208/s12249-021-02137-0.
4
Amorphization of Low Soluble Drug with Amino Acids to Improve Its Therapeutic Efficacy: a State-of-Art-Review.氨基酸对低溶性药物进行非晶化以提高其治疗效果:综述。
AAPS PharmSciTech. 2023 Dec 7;24(8):253. doi: 10.1208/s12249-023-02709-2.
5
Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.聚合物无定形固体分散体:生物药剂学分类系统II类药物的非晶化、结晶、稳定化、固态表征及水相增溶综述
J Pharm Sci. 2016 Sep;105(9):2527-2544. doi: 10.1016/j.xphs.2015.10.008. Epub 2016 Jan 23.
6
Emerging trends in the stabilization of amorphous drugs.无定形药物稳定化的新兴趋势。
Int J Pharm. 2013 Aug 30;453(1):65-79. doi: 10.1016/j.ijpharm.2012.04.066. Epub 2012 Apr 28.
7
Microwave-Induced In Situ Amorphization: A New Strategy for Tackling the Stability Issue of Amorphous Solid Dispersions.微波诱导原位非晶化:解决非晶态固体分散体稳定性问题的新策略。
Pharmaceutics. 2020 Jul 11;12(7):655. doi: 10.3390/pharmaceutics12070655.
8
Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.喷雾干燥吲哚美辛无定形策略的分子结构及对固有溶出度的影响。
Eur J Pharm Sci. 2019 Mar 1;129:1-9. doi: 10.1016/j.ejps.2018.12.010. Epub 2018 Dec 13.
9
Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.介孔碳酸钙作为无定形塞来昔布的相稳定剂——提高难溶性药物生物利用度的一种方法。
Adv Healthc Mater. 2013 Nov;2(11):1469-76. doi: 10.1002/adhm.201200391. Epub 2013 May 23.
10
A Comparative Study of the Pharmaceutical Properties between Amorphous Drugs Loaded-Mesoporous Silica and Pure Amorphous Drugs Prepared by Solvent Evaporation.载有无定形药物的介孔二氧化硅与通过溶剂蒸发制备的纯无定形药物之间药学性质的比较研究。
Pharmaceuticals (Basel). 2022 Jun 9;15(6):730. doi: 10.3390/ph15060730.

引用本文的文献

1
Calorimetric Monitoring of the Sub-T Crystal Growth in Molecular Glasses: The Case of Amorphous Nifedipine.分子玻璃中亚稳 T 晶体生长的量热法监测:以非晶态硝苯地平为例。
Molecules. 2025 Apr 9;30(8):1679. doi: 10.3390/molecules30081679.
2
Electrospun Fiber Mats with Metronidazole: Design, Evaluation, and Release Kinetics.含甲硝唑的电纺纤维垫:设计、评估及释放动力学
J Phys Chem B. 2025 May 8;129(18):4535-4546. doi: 10.1021/acs.jpcb.5c00873. Epub 2025 Apr 3.
3
A drug-drug co-amorphous system for highly improved solubility of breviscapine: an experimental and computational study.

本文引用的文献

1
Studying the Impact of the Temperature and Sorbed Water during Microwave-Induced Amorphization: A Case Study of Celecoxib and Polyvinylpyrrolidone.研究微波诱导非晶化过程中温度和吸附水的影响:以塞来昔布和聚乙烯吡咯烷酮为例
Pharmaceutics. 2021 Jun 15;13(6):886. doi: 10.3390/pharmaceutics13060886.
2
Microwave-Induced in Situ Drug Amorphization Using a Mixture of Polyethylene Glycol and Polyvinylpyrrolidone.采用聚乙二醇和聚乙烯吡咯烷酮混合物的微波诱导原位药物无定形化。
J Pharm Sci. 2021 Sep;110(9):3221-3229. doi: 10.1016/j.xphs.2021.05.010. Epub 2021 May 19.
3
Utilizing Laser Activation of Photothermal Plasmonic Nanoparticles to Induce On-Demand Drug Amorphization inside a Tablet.
用于显著提高灯盏花素溶解度的药物-药物共无定形体系:一项实验与计算研究
Sci Rep. 2024 Dec 28;14(1):31183. doi: 10.1038/s41598-024-82524-2.
4
Highly Drug-Loaded Nanoaggregate Microparticles for Pulmonary Delivery of Cyclosporin A.高载药量纳米复合微球经肺部递释环孢素 A
Int J Nanomedicine. 2024 Jul 24;19:7529-7546. doi: 10.2147/IJN.S470134. eCollection 2024.
5
Mechanochemical Synthesis of Resveratrol-Piperazine Cocrystals.白藜芦醇 - 哌嗪共晶的机械化学合成
Materials (Basel). 2024 Jun 27;17(13):3145. doi: 10.3390/ma17133145.
6
Polymeric Amorphous Solid Dispersions of Dasatinib: Formulation and Ecotoxicological Assessment.达沙替尼的聚合物无定形固体分散体:制剂与生态毒理学评估。
Pharmaceutics. 2024 Apr 18;16(4):551. doi: 10.3390/pharmaceutics16040551.
7
Ivermectin-Loaded Mesoporous Silica and Polymeric Nanocapsules: Impact on Drug Loading, In Vitro Solubility Enhancement, and Release Performance.载伊维菌素的介孔二氧化硅和聚合物纳米胶囊:对药物负载、体外溶解度提高及释放性能的影响
Pharmaceutics. 2024 Feb 26;16(3):325. doi: 10.3390/pharmaceutics16030325.
8
Advancing Drug Delivery Paradigms: Polyvinyl Pyrolidone (PVP)-Based Amorphous Solid Dispersion for Enhanced Physicochemical Properties and Therapeutic Efficacy.推进药物递送模式:基于聚乙烯吡咯烷酮(PVP)的无定形固体分散体以增强理化性质和治疗效果。
Polymers (Basel). 2024 Jan 20;16(2):286. doi: 10.3390/polym16020286.
9
Statistical analysis of the storage time of finished product infusion.成品输液储存时间的统计分析。
J Int Med Res. 2024 Jan;52(1):3000605231222231. doi: 10.1177/03000605231222231.
10
Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A.用于环孢素A肺部递送的大型中空颗粒的研发。
Pharmaceutics. 2023 Aug 25;15(9):2204. doi: 10.3390/pharmaceutics15092204.
利用激光激活光热等离子体纳米颗粒在片剂内部按需诱导药物非晶化。
Mol Pharm. 2021 Jun 7;18(6):2254-2262. doi: 10.1021/acs.molpharmaceut.1c00077. Epub 2021 May 5.
4
Microwave induced in situ amorphisation facilitated by crystalline hydrates.由结晶水合物促进的微波诱导原位非晶化
Eur J Pharm Sci. 2021 Aug 1;163:105858. doi: 10.1016/j.ejps.2021.105858. Epub 2021 Apr 19.
5
Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.壳聚糖-葡萄糖醛酸缀合物修饰的介孔硅纳米粒子:用于结直肠癌治疗的智能 pH 响应型和受体靶向系统。
Carbohydr Polym. 2021 Jun 1;261:117893. doi: 10.1016/j.carbpol.2021.117893. Epub 2021 Mar 3.
6
Effect of co-milling on dissolution rate of poorly soluble drugs.共研磨对难溶性药物溶出速率的影响。
Int J Pharm. 2021 Mar 15;597:120312. doi: 10.1016/j.ijpharm.2021.120312. Epub 2021 Feb 1.
7
Liquid CO Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem.液 CO2 法制备介孔硅纳米颗粒用于美罗培南的 pH 响应型口服给药
ACS Biomater Sci Eng. 2021 May 10;7(5):1836-1853. doi: 10.1021/acsbiomaterials.0c01284. Epub 2021 Jan 7.
8
The Influence of Temperature and Viscosity of Polyethylene Glycol on the Rate of Microwave-Induced In Situ Amorphization of Celecoxib.温度和聚乙二醇黏度对塞来昔布微波诱导原位无定形化速率的影响。
Molecules. 2020 Dec 29;26(1):110. doi: 10.3390/molecules26010110.
9
The Use of Glycerol as an Enabling Excipient for Microwave-Induced In Situ Drug Amorphization.甘油作为一种赋形剂在微波诱导原位药物无定形化中的应用。
J Pharm Sci. 2021 Jan;110(1):155-163. doi: 10.1016/j.xphs.2020.10.013. Epub 2020 Oct 13.
10
Microwave-Induced In Situ Amorphization: A New Strategy for Tackling the Stability Issue of Amorphous Solid Dispersions.微波诱导原位非晶化:解决非晶态固体分散体稳定性问题的新策略。
Pharmaceutics. 2020 Jul 11;12(7):655. doi: 10.3390/pharmaceutics12070655.